ProQR Therapeutics N.V. buy Oppenheimer Holdings Inc.
Start price
10.01.25
/
50%
€2.36
Target price
10.01.26
€14.62
Performance (%)
-37.64%
End price
11.01.26
€1.47
Summary
This prediction ended on 11.01.26 with a price of €1.47. The BUY prediction by Oppenheimer_Holdings for ProQR Therapeutics N.V. performed very badly with a performance of -37.64%. Oppenheimer_Holdings has a follow-up prediction for ProQR Therapeutics N.V. where he still thinks ProQR Therapeutics N.V. is a Buy. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | 0.000% | 0.000% | -47.416% |
| iShares Core DAX® | 1,43 % | 2,63 % | 12,46 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % | 1,25 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % | 27,38 % |
| iShares S&P 500 | 1,92 % | 1,16 % | 1,63 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $15.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Current prediction by Oppenheimer_Holdings for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.38
13.05.25
13.05.25
€8.10
13.05.26
13.05.26
-11.80%
20.02.26
20.02.26
